ABVC BioPharma Inc. Common Stock (ABVC)

About ABVC

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for a…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

16

Website

abvcpharma.com/

Fundamentals

1-day range

$0.89$0.95

Market cap

$27.09M

P/E (trailing)

—

P/E (forward)

-2.13

EPS (trailing)

$-0.42

Dividend yield

—

Beta

0.53

Avg. volume

146.5K

Dividend pay date

May 8, 2019

ABVC BioPharma Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• ABVC

  ABVC BioPharma Inc. Common Stock

  $0.8251

  ▲ 3.66%
  Market cap $27.09MP/E —
  $0.7069$3.4
• KYNB

  Kyntra Bio Inc. Common Stock

  $8.02

  ▲ 1.26%
  Market cap $28.26MP/E 0.17
  $6.32$12.6
• RMTI

  Rockwell Medical Inc. Common Stock

  $8.22

  ▲ 6.06%
  Market cap $28.26MP/E —
  $4.89$21
• GRCE

  Grace Therapeutics Inc. Common Stock

  $2.13

  ▼ 1.39%
  Market cap $28.44MP/E —
  $1.79$5.18
• MIRA

  MIRA Pharmaceuticals Inc. Common Stock

  $0.75

  ▼ 2.60%
  Market cap $28.50MP/E —
  $0.6$2.45
• BTAI

  BioXcel Therapeutics Inc. Common Stock

  $0.1824

  ▼ 74.63%
  Market cap $25.63MP/E —
  $0.1569$4.29
• AYTU

  Aytu BioPharma Inc. Common Stock

  $2.27

  ▲ 1.34%
  Market cap $25.01MP/E —
  $1.65$3.07

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 12 Health Care Stocks Moving In Friday's After-Market Session
  Benzinga · 8/28/2026
• 12 Health Care Stocks Moving In Thursday's After-Market Session
  Benzinga · 8/27/2026
• ABVC BioPharma Postpones Biokey (Cayman) Share Distribution, Rescheduled For August 21, 2026
  Benzinga · 8/12/2026

Institutional Ownership

March 31, 2026

Total shares held

729.9K

Total value held

$708.1K

Institutional holders

13